Charles Schwab’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.3M | Sell |
432,624
-182,262
| -30% | -$8.56M | ﹤0.01% | 1665 |
|
|
2025
Q1 | $27.1M | Buy |
614,886
+9,638
| +2% | +$425K | 0.01% | 1454 |
|
|
2024
Q4 | $21.9M | Buy |
605,248
+3,021
| +0.5% | +$109K | ﹤0.01% | 1654 |
|
|
2024
Q3 | $19.3M | Buy |
602,227
+73,613
| +14% | +$2.36M | ﹤0.01% | 1715 |
|
|
2024
Q2 | $19.9M | Buy |
528,614
+10,641
| +2% | +$401K | ﹤0.01% | 1682 |
|
|
2024
Q1 | $25.5M | Buy |
517,973
+16,906
| +3% | +$832K | 0.01% | 1469 |
|
|
2023
Q4 | $18.3M | Buy |
501,067
+77,303
| +18% | +$2.82M | ﹤0.01% | 1645 |
|
|
2023
Q3 | $9.8M | Buy |
423,764
+59,138
| +16% | +$1.37M | ﹤0.01% | 1918 |
|
|
2023
Q2 | $9.56M | Buy |
364,626
+53,247
| +17% | +$1.4M | ﹤0.01% | 1928 |
|
|
2023
Q1 | $8.01M | Buy |
311,379
+404
| +0.1% | +$10.4K | ﹤0.01% | 1977 |
|
|
2022
Q4 | $8.09M | Buy |
310,975
+73,432
| +31% | +$1.91M | ﹤0.01% | 1975 |
|
|
2022
Q3 | $6.78M | Buy |
237,543
+31,560
| +15% | +$901K | ﹤0.01% | 2053 |
|
|
2022
Q2 | $5.07M | Buy |
205,983
+8,359
| +4% | +$206K | ﹤0.01% | 2180 |
|
|
2022
Q1 | $11.2M | Buy |
197,624
+6,365
| +3% | +$359K | ﹤0.01% | 1890 |
|
|
2021
Q4 | $11.9M | Buy |
191,259
+3,029
| +2% | +$188K | ﹤0.01% | 1912 |
|
|
2021
Q3 | $11.9M | Sell |
188,230
-4,914
| -3% | -$312K | ﹤0.01% | 1902 |
|
|
2021
Q2 | $15.9M | Buy |
193,144
+13,358
| +7% | +$1.1M | 0.01% | 1736 |
|
|
2021
Q1 | $13.2M | Buy |
179,786
+5,920
| +3% | +$436K | ﹤0.01% | 1792 |
|
|
2020
Q4 | $12.6M | Buy |
173,866
+32,358
| +23% | +$2.35M | 0.01% | 1714 |
|
|
2020
Q3 | $6.75M | Buy |
141,508
+54,187
| +62% | +$2.58M | ﹤0.01% | 1919 |
|
|
2020
Q2 | $3.67M | Buy |
87,321
+27,077
| +45% | +$1.14M | ﹤0.01% | 2174 |
|
|
2020
Q1 | $1.63M | Buy |
60,244
+1,313
| +2% | +$35.5K | ﹤0.01% | 2342 |
|
|
2019
Q4 | $2.27M | Buy |
+58,931
| New | +$2.27M | ﹤0.01% | 2375 |
|